The restored expression of S704D-LOXL3 in AK2-deficient cells efficiently rescued the resistance of tumor cells to chemotherapy, further validating that LOXL3 acts downstream of AK2 (Fig. 4k). This evidence concerns the gene AK2 and neoplasm.